Old Web
English
Sign In
Acemap
>
authorDetail
>
John Robert Caton
John Robert Caton
University of South Florida
Pathology
Chemotherapy
Medicine
Performance status
Carboplatin
2
Papers
164
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
SELECT: Randomized phase III study of docetaxel (D) or pemetrexed (P) with or without cetuximab (C) in recurrent or progressive non-small cell lung cancer (NSCLC) after platinum-based therapy.
2017
Journal of Clinical Oncology
Edward S. Kim
Marcus A. Neubauer
Allen Lee Cohn
Lee S. Schwartzberg
Lawrence E. Garbo
John Robert Caton
Francisco Robert
Terry Katz
Sreenivas Chittoor
Lorinda Simms
Scott Saxman
Show All
Source
Cite
Save
Citations (7)
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer
2009
Journal of Clinical Oncology
Craig H. Reynolds
Coleman K. Obasaju
Michael J. Schell
Xueli Li
Zhong Zheng
David Boulware
John Robert Caton
Linda Cheryl DeMarco
Mark O'Rourke
Gail Shaw Wright
Kristi A. Boehm
Lina Asmar
Jane Bromund
Guangbin Peng
Matthew J. Monberg
Gerold Bepler
Show All
Source
Cite
Save
Citations (157)
1